Dapa-Z 10mg Film-Coated Tablets contain dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage type 2 diabetes mellitus, chronic heart failure with reduced ejection fraction, and chronic kidney disease in adults. citeturn0search0

Dosage:

• Type 2 Diabetes: 10 mg once daily, with or without food.

• Heart Failure and Chronic Kidney Disease: 10 mg once daily, alongside other prescribed therapies.

Initiation in patients with an estimated glomerular filtration rate (eGFR) below 15 mL/min/1.73 m² is not recommended. citeturn0search0

Contraindications: Not suitable for individuals with hypersensitivity to dapagliflozin or those with severe renal impairment. citeturn0search0

Precautions: Monitor for signs of dehydration, hypotension, and urinary tract infections. Use with caution in patients with liver or kidney issues, and those on diuretics. citeturn0search0

Pregnancy and Lactation: Not recommended during the second and third trimesters of pregnancy or while breastfeeding. citeturn0search0

Side Effects: May include genital infections, urinary tract infections, dizziness, rash, back pain, and changes in urination. citeturn0search0

Always consult a healthcare provider before starting new medications to ensure they align with your health needs.